Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil
      Biotech

      GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil

      July 25, 2022
      SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors
      Biotech

      SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors

      July 25, 2022
      BioCryst to Present at Upcoming Investor Conference
      Biotech

      BioCryst to Present at Upcoming Investor Conference

      July 25, 2022
      Immunocore Announces $140 Million Private Placement Financing
      Biotech

      Immunocore Announces $140 Million Private Placement Financing

      July 25, 2022
      Codexis Announces CEO Transition Effective August 9, 2022
      Biotech

      Codexis Announces CEO Transition Effective August 9, 2022

      July 25, 2022
      FibroGen to Report Second Quarter 2022 Financial Results
      Biotech

      FibroGen to Report Second Quarter 2022 Financial Results

      July 25, 2022
      UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients
      Biotech

      UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients

      July 25, 2022
      Pluri CEO Issues Shareholder Update
      Biotech

      Pluri CEO Issues Shareholder Update

      July 25, 2022
      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

      July 25, 2022
      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      July 22, 2022
      « 1 … 121 122 123 124 125 … 129 »

       

      LATEST NEWS

      • Investing News Goldman Sachs Earnings Lead Q1 Reports
      • Investing News Starbucks Store Portfolio Reset Boosts Unit Economics
      • Investing News Uber Q4 2025 Earnings: What Investors Should Know
      • Investing News Samsung’s Profit Surge in Q4 2026
      • Investing News NinjaOne Surpasses $500M ARR Milestone

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026